(Bloomberg) -- Novavax Inc. shares fell 19% after US regulators placed a hold on the company’s experimental vaccines because a study volunteer developed a serious nerve disorder. The pause ...

Novavax's share price fall more than 18% on the news. "Our goal is to successfully resolve this matter and to start our Phase ...

The company doesn’t believe causality has been established and it’s working with regulators to resolve the issue, said Robert Walker, Novavax’s chief medical officer. Novavax shares were ...

Shares of Novavax (NASDAQ:NVAX ... this observation and resolve the clinical hold,” said Chief Medical Officer Robert Walker.

we are committed to working expeditiously to fulfill requests for more information from the FDA," Novavax Chief Medical Officer Robert Walker said. "Our goal is to successfully resolve this matter ...

Novavax announced that the U.S. Food and Drug ... understand this observation and resolve the clinical hold,” said Robert Walker, MD, Chief Medical Officer, Novavax. “It is important to ...

(RTTNews) - Novavax, Inc. (NVAX ... to better understand this observation and resolve the clinical hold," said Robert Walker, Chief Medical Officer, Novavax. The COVID-19 IND for Novavax's ...

Novavax said a participant enrolled in a mid ... start our Phase 3 trial as soon as possible,” Chief Medical Officer Robert Walker said. Still, the pause fueled investor worries over the company ...

Robert Smith has suggested that The Cure could call it a day in just a few years, as they prepare to release their new album, Songs of a Lost World. The English singer appeared in a rare and ...

Supreme Court denies request to stay execution of Robert Robertson by CBSNews.com on Scribd Texas prosecutors had urged the U.S. Supreme Court in a filing Wednesday evening to reject the emergency ...

Robert Roberson’s execution was put on hold after the Texas House subpoenaed him for testimony about the questionable diagnosis of shaken baby syndrome in his case. By J. David Goodman The ...